rhodamine 123 has been researched along with HIV Coinfection in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoyama, H; Fukushima, K; Kobuchi, S; Mizuhara, K; Sugioka, N; Takada, K | 1 |
| Caldarola, G; Cauda, R; Lucia, MB; Rumi, C; Rutella, S; Ventura, G | 1 |
| Cauda, R; Leone, G; Lucia, MB; Rutella, S; Vella, S | 1 |
3 other study(ies) available for rhodamine 123 and HIV Coinfection
| Article | Year |
|---|---|
Time-dependent interaction of ritonavir in chronic use: the power balance between inhibition and induction of P-glycoprotein and cytochrome P450 3A.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; HIV Infections; HIV Protease Inhibitors; Humans; Male; Midazolam; Rats; Rats, Wistar; Rhodamine 123; Ritonavir | 2013 |
Detection of P-glycoprotein efflux activity on peripheral blood lymphocyte subsets from HIV+ patients.
Topics: Antigens, CD; ATP Binding Cassette Transporter, Subfamily B, Member 1; Flow Cytometry; Fluorescent Dyes; HIV Infections; Humans; Immunohistochemistry; Immunophenotyping; Lymphocyte Subsets; Lymphocytes; Rhodamine 123 | 1997 |
HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
Topics: Adult; Antigens, CD34; Antiretroviral Therapy, Highly Active; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport, Active; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Fluorescent Dyes; Hematopoietic Stem Cells; HIV Infections; HIV Protease Inhibitors; Humans; In Vitro Techniques; Indinavir; Lymphocytes; Male; Nelfinavir; Rhodamine 123; Ritonavir; RNA, Viral; Saquinavir | 2001 |